420 related articles for article (PubMed ID: 17658199)
21. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
22. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
[TBL] [Abstract][Full Text] [Related]
23. Influence of exposure intensity on the efficiency and speed of transmission of Foot-and-mouth disease.
Quan M; Murphy CM; Zhang Z; Durand S; Esteves I; Doel C; Alexandersen S
J Comp Pathol; 2009 May; 140(4):225-37. PubMed ID: 19215941
[TBL] [Abstract][Full Text] [Related]
24. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease.
Parida S; Cox SJ; Reid SM; Hamblin P; Barnett PV; Inoue T; Anderson J; Paton DJ
Vaccine; 2005 Oct; 23(44):5186-95. PubMed ID: 16039761
[TBL] [Abstract][Full Text] [Related]
25. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination.
Nagendrakumar SB; Hong NT; Geoffrey FT; Jacqueline MM; Andrew D; Michelle G; Van Phuc K; Ngon QV; Phuong le TT; Phuc NN; Hanh TX; Van Hung V; Quynhanh le T; Tan TM; Long NT; Wilna V
Vaccine; 2015 Aug; 33(36):4513-9. PubMed ID: 26192355
[TBL] [Abstract][Full Text] [Related]
26. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody.
Sørensen KJ; de Stricker K; Dyrting KC; Grazioli S; Haas B
Arch Virol; 2005 Apr; 150(4):805-14. PubMed ID: 15645377
[TBL] [Abstract][Full Text] [Related]
28. Direct contact transmission of three different foot-and-mouth disease virus strains in swine demonstrates important strain-specific differences.
Pacheco JM; Tucker M; Hartwig E; Bishop E; Arzt J; Rodriguez LL
Vet J; 2012 Aug; 193(2):456-63. PubMed ID: 22342891
[TBL] [Abstract][Full Text] [Related]
29. Effect of FMD vaccine antigen payload on protection, sub-clinical infection and persistence following needle challenge in sheep.
Madhanmohan M; Nagendrakumar SB; Narasu ML; Srinivasan VA
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e7-13. PubMed ID: 19896714
[TBL] [Abstract][Full Text] [Related]
30. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
31. Vaccination against foot-and-mouth disease II: Regaining FMD-free status.
Backer JA; Engel B; Dekker A; van Roermund HJ
Prev Vet Med; 2012 Nov; 107(1-2):41-50. PubMed ID: 22726463
[TBL] [Abstract][Full Text] [Related]
32. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
[TBL] [Abstract][Full Text] [Related]
33. Comparable sensitivity and specificity in three commercially available ELISAs to differentiate between cattle infected with or vaccinated against foot-and-mouth disease virus.
Moonen P; van der Linde E; Chénard G; Dekker A
Vet Microbiol; 2004 Apr; 99(2):93-101. PubMed ID: 15019100
[TBL] [Abstract][Full Text] [Related]
34. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge.
Cox SJ; Parida S; Voyce C; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
Vaccine; 2007 Nov; 25(44):7687-95. PubMed ID: 17913309
[TBL] [Abstract][Full Text] [Related]
35. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
[TBL] [Abstract][Full Text] [Related]
36. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
37. Comparison of sensitivity and specificity in three commercial foot-and-mouth disease virus non-structural protein ELISA kits with swine sera in Taiwan.
Chen SP; Ellis TM; Lee MC; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR
Vet Microbiol; 2007 Jan; 119(2-4):164-72. PubMed ID: 17112687
[TBL] [Abstract][Full Text] [Related]
38. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
[TBL] [Abstract][Full Text] [Related]
39. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.
Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Paton DJ; Barnett PV
Vaccine; 2005 Jan; 23(9):1106-13. PubMed ID: 15629353
[TBL] [Abstract][Full Text] [Related]
40. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle.
Paton DJ; de Clercq K; Greiner M; Dekker A; Brocchi E; Bergmann I; Sammin DJ; Gubbins S; Parida S
Vaccine; 2006 Oct; 24(42-43):6503-12. PubMed ID: 16872727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
